CLDI
Price
$0.73
Change
-$0.04 (-5.19%)
Updated
Jul 25 closing price
Capitalization
25.2M
ORYZF
Price
$3.28
Change
-$0.00 (-0.00%)
Updated
Jul 24 closing price
Capitalization
250.96M
Interact to see
Advertisement

CLDI vs ORYZF

Header iconCLDI vs ORYZF Comparison
Open Charts CLDI vs ORYZFBanner chart's image
Calidi Biotherapeutics
Price$0.73
Change-$0.04 (-5.19%)
Volume$2.75M
Capitalization25.2M
Oryzon Genomics SA
Price$3.28
Change-$0.00 (-0.00%)
Volume$1K
Capitalization250.96M
CLDI vs ORYZF Comparison Chart in %
Loading...
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORYZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDI vs. ORYZF commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDI is a Hold and ORYZF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (CLDI: $0.73 vs. ORYZF: $3.28)
Brand notoriety: CLDI and ORYZF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDI: 10% vs. ORYZF: 61%
Market capitalization -- CLDI: $25.2M vs. ORYZF: $250.96M
CLDI [@Biotechnology] is valued at $25.2M. ORYZF’s [@Biotechnology] market capitalization is $250.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDI’s FA Score shows that 0 FA rating(s) are green whileORYZF’s FA Score has 1 green FA rating(s).

  • CLDI’s FA Score: 0 green, 5 red.
  • ORYZF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLDI and ORYZF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDI’s TA Score shows that 5 TA indicator(s) are bullish while ORYZF’s TA Score has 0 bullish TA indicator(s).

  • CLDI’s TA Score: 5 bullish, 5 bearish.
  • ORYZF’s TA Score: 0 bullish, 2 bearish.
According to our system of comparison, CLDI is a better buy in the short-term than ORYZF.

Price Growth

CLDI (@Biotechnology) experienced а +22.98% price change this week, while ORYZF (@Biotechnology) price change was -0.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CLDI is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORYZF($251M) has a higher market cap than CLDI($25.2M). ORYZF YTD gains are higher at: 102.469 vs. CLDI (-36.522). ORYZF has higher annual earnings (EBITDA): 834K vs. CLDI (-17.73M). CLDI has more cash in the bank: 10.6M vs. ORYZF (8.44M). CLDI has less debt than ORYZF: CLDI (4.71M) vs ORYZF (13.4M). CLDI (0) and ORYZF (0) have equivalent revenues.
CLDIORYZFCLDI / ORYZF
Capitalization25.2M251M10%
EBITDA-17.73M834K-2,125%
Gain YTD-36.522102.469-36%
P/E RatioN/AN/A-
Revenue00-
Total Cash10.6M8.44M126%
Total Debt4.71M13.4M35%
TECHNICAL ANALYSIS
Technical Analysis
CLDIORYZF
RSI
ODDS (%)
Bearish Trend 2 days ago
17%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
25%
Momentum
ODDS (%)
Bearish Trend 2 days ago
61%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
21%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
38%
Bearish Trend 2 days ago
20%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
32%
Bullish Trend 2 days ago
18%
Advances
ODDS (%)
Bullish Trend 3 days ago
51%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
31%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORYZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTCWX13.85N/A
N/A
Fidelity Advisor Asset Manager 20% C
RYRIX57.97N/A
N/A
Rydex Retailing Inv
FMIHX15.70N/A
N/A
FMI Large Cap Investor
OFAFX27.68N/A
N/A
Olstein All Cap Value Adv
CRRVX9.57N/A
N/A
Columbia Real Estate Equity Inst2

CLDI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDI has been loosely correlated with ORYZF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDI jumps, then ORYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDI
1D Price
Change %
CLDI100%
-5.43%
ORYZF - CLDI
37%
Loosely correlated
N/A
DYN - CLDI
36%
Loosely correlated
+7.68%
LENZ - CLDI
32%
Poorly correlated
-5.33%
RYTM - CLDI
30%
Poorly correlated
-0.94%
PROK - CLDI
29%
Poorly correlated
+0.92%
More

ORYZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORYZF has been loosely correlated with CLDI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ORYZF jumps, then CLDI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORYZF
1D Price
Change %
ORYZF100%
N/A
CLDI - ORYZF
37%
Loosely correlated
-5.43%
PPBT - ORYZF
28%
Poorly correlated
-11.07%
DRUG - ORYZF
25%
Poorly correlated
+10.83%
GNNSF - ORYZF
24%
Poorly correlated
N/A
IPSC - ORYZF
20%
Poorly correlated
-5.17%
More